Remove companies pharmaceutical-care-management-association
article thumbnail

CCC Hosts Eli Lilly and Company for Panel Discussion on Innovation and Copyright Compliance

Velocity of Content

Lilly strives to not only create high-quality medicines, but also ensure that the benefits and risks of medications are continuously monitored and well-understood by regulators, health care professionals and patients. Joining the panel are: Christina Bennett-McNew is the Associate Director of Library Operations at Eli Lilly and Company.

article thumbnail

Herbert Smith Freehills advises sole sponsor and overall coordinators on Cutia Therapeutics' Hong Kong IPO ????????????????????????????????????????

Herbert Smith Freehills

Cutia Therapeutics is an R&D-driven, dermatology-focused biopharmaceutical company. The company focuses on broader dermatology treatment and care therapeutic areas, including localised adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Better Information Management Helps Boost the Intellectual Capital of Medical Affairs Teams

Velocity of Content

By leveraging this capital, companies can take the lead in their industry as innovators and open themselves to new opportunities ahead of their competitors. By leveraging this capital, companies can take the lead in their industry as innovators and open themselves to new opportunities ahead of their competitors.

Designs 52
article thumbnail

Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO ?????????????????????????????????

Herbert Smith Freehills

3D Medicines specialises in the research and development of oncology therapies for cancer patients, especially those who require long-term care. We are delighted to have worked with 3D Medicines, a leading bio-pharmaceutical company, on its successful listing on the Hong Kong Stock Exchange,” said Beijing partner Isaac Chen. "We

article thumbnail

Undisclosed Information and Patents

IP and Legal Filings

Giving due importance to the intellectual labour associated with the innovation is what makes the process of innovation a continuous cycle. Under Covid-19, the evolving era for pharmaceuticals industries requires them for having an effective and focused IPR strategy. For all these, a focused IPR strategy is inevitable.

article thumbnail

Guest Post: Assessing Responses to the PTO’s 2021 Patent Eligibility Study

Patently-O

Companies and trade associations were broadly classified as “High Tech” (18%) or “Life Sciences” (14%). Notable commenters in this camp include the American Civil Liberties Union (ACLU), Google, and the Association of American Medical Colleges (AAMC). . The PTO released its public request for information (RFI) on July 9, 2021.

Patent 121
article thumbnail

IP as Collateral

IIPRD

A report on “IP Backed Financing – Overview of Trends” by Relecura shows that companies like General Motors, Avago, Alcatel Lucent, Kodak, Freescale, and Seagate have raised significant financing as collateral. It has been seen that such transactions for raising loans are used when companies run out of options to pledge tangible assets.

IP 40